History

GelStat Corporation is a company engaged in research, development and marketing of OTC (over-the-counter, non-prescription) consumer healthcare products, targeted at the migraine and sleep therapy market segments. GelStat Corporation founded May, 2002, GelStat became a publicly traded company through a merger with Developed Technology Resource, Inc. on April 30, 2003.

Our Approach

GelStat Corporation is a healthcare company dedicated to bringing to market advanced consumer healthcare products in a cost-effective manner. Product development efforts are focused on meeting unmet needs in the migraine and sleep therapy OTC market segments - areas where we can improve efficacy, safety, and/or convenience. While we engage in scientific, academic and clinical research, we are primarily a marketing driven company, dedicated to innovation and committed to building a portfolio of products with significant commercial potential.

Our efforts center on developing products for migraine therapy and to improve sleep, both multi-billion dollar global markets. We believe our first product, GelStat™ Migraine, will become an important addition to the treatment arsenal of 25-50 million Americans with migraine type headaches. GelStat™ Sleep, the second product in our development pipeline, is expected to benefit the approximately 70 million “problem sleepers” in the U.S. These products demonstrate GelStat's commitment and ability to get to market quickly and economically with products that address major unmet needs.